Kemin Industries showcased FloraGLO® Lutein, the world’s most clinically studied lutein brand – supported by 130+ human clinical studies demonstrating the role of lutein in supporting health across all life stages, including vision, cognitive function and skin health – at Vitafoods Asia 2026 which ended recently.
Eye health continues to be a growing priority across Asia Pacific, a region that carries nearly two-thirds of the global burden of moderate-to-severe vision impairment.[1] Kemin has used Vitafoods Asia to build an interactive FloraGLO® EyeQ Station for attendees to check on their EyeQ score which assesses the levels of macular pigmentation in the eye, while educating them on the role of carotenoids such as lutein and zeaxanthin in supporting health and nutrition across all life stages.
Masafumi Hashimoto, Director of Sales for APAC at Kemin Human Nutrition said, “Over 90% of adults aged 40+ across Asia Pacific are concerned about their vision health.[2] Yet, average dietary intake of lutein and zeaxanthin is estimated at just 1-3 mg per day[3] — well below the 10mg level shown in clinical research to provide meaningful benefits. This represents a dietary gap of up to 90% and highlights the need for effective nutritional solutions that proactively support long-term wellbeing.”
As Kemin is also celebrating the 30th anniversary of FloraGLO®, it is proud to promote the industry understanding of lutein, from its established role in eye health to its growing potential across cognitive function, skin health and lifelong wellbeing.
[1] Elhusseiny A, ‘Combating vision loss in Asia Pacific: A roadmap to 2030’, World Economic Forum, 2024
[2] Roche, ‘Insights Report: Vision Care in APAC – Understanding the Societal and Economic Burden’, 2025
[3] Sae-Lao W, Wunjuntuk K, Techakriengkrai T, Sirichakwal PP. Consumption of Lutein and Zeaxanthin and Its Relation to the Level of Macular Pigment Optical Density in Thai Subjects. J Nutr Metab. 2022 Apr 15;2022:6321778. doi: 10.1155/2022/6321778. PMID: 35462865; PMCID: PMC9033377
